ADAR1 Capital Management, LLC bought $1.6M of NXTC
owner at NextCure, Inc.. 329,153 shares at an average of $4.93, traded Jul 30, 2026, filed Aug 3, 2026.
Score components
- +12Role10% owner
- +25Trade size$1.6M at market
- +10Relative to holdingsHoldings up 84%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001940272-26-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +50,000 | $4.97 | $249k | 443,266 | Aug 3, 2026 |
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +20,000 | $5.00 | $100k | 463,266 | Aug 3, 2026 |
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +20,000 | $5.00 | $100k | 483,266 | Aug 3, 2026 |
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +25,000 | $4.81 | $120k | 508,266 | Aug 3, 2026 |
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +100,000 | $4.90 | $490k | 608,266 | Aug 3, 2026 |
| Jul 30, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +77,850 | $4.96 | $386k | 686,116 | Aug 3, 2026 |
| Jul 31, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +3,300 | $4.98 | $16k | 689,416 | Aug 3, 2026 |
| Jul 31, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +25,000 | $4.98 | $125k | 714,416 | Aug 3, 2026 |
| Jul 31, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +8,003 | $4.80 | $38k | 722,419 | Aug 3, 2026 |
Related signals
Other insiders at NextCure, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | NXTCsell NextCure, Inc. | Simcere Zaiming, Inc. other | $185k 30,000 shares | -9% | |
| 16Weak | NXTCbuy NextCure, Inc. | ADAR1 Capital Management, LLC owner | $88k 17,608 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.